Evolus, Inc. (EOLS)

Evolus, Inc. (EOLS) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $6.69, up 0.90% on the day, which values the company at $442.8M. Price as of 18 Nov 2026, 12:31 UTC, from Yahoo Finance.

Key facts

Share price
$6.69+0.90% today
Market value
$442.8M
Forward P/E
23.3×
Funk Score
44/100
200-week average
$9.5730% below
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Evolus, Inc. in more detail

EOLS trades at 23.3× next year's expected earnings, 1.4× sales. It sits 30% below its 200-week average of $9.57.

Over the last five fiscal years Evolus, Inc. has compounded revenue 39.4% a year. Its Funk Score is 44 out of 100 (financial strength 1.3, profitability 2.0, growth 10.0, each out of 10).

In its favour: Five straight years of revenue growth. Worth checking: Altman Z in the distress zone; Weak Piotroski score.

Evolus, Inc. (EOLS): questions and answers

What is Evolus, Inc.'s market cap?

Evolus, Inc. is valued at $442.8M at a share price of $6.69.

Is EOLS above its 200-week moving average?

No. EOLS is 30.1% below its 200-week average of $9.57. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Evolus, Inc. growing?

Over the last five fiscal years Evolus, Inc.'s revenue grew 39.4% a year.

Does EOLS pay a dividend?

Evolus, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Evolus, Inc. (EOLS) stock: price, valuation and fundamentals”, data as of 18 November 2026. https://funkfolio.com/stock/EOLS

Underlying data: Yahoo Finance; company filings with the SEC.